🔎 Trials Near Me

Home › Obesity › Minnesota › Minneapolis

Pag-aaral pangklinika para sa Obesity sa Minneapolis, MN

Isang pag-aaral para sa Obesity ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Minneapolis. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Nagre-recruitPhase 3
  • International Diabetes Center, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07533175

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Nagre-recruitPhase 3
  • International Diabetes Center, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07564414

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Nagre-recruitPhase 3
  • University of Minnesota, Minneapolis
Edad 8 hanggang 18 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07253285

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Nagre-recruitPhase 3
  • University of Minnesota Masonic Children's Hospital, Minneapolis
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06672549

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Nagre-recruitPhase 3
  • Minneapolis Heart Institute Foundation, Minneapolis
Edad 45 hanggang 99 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Nagre-recruitPhase 3
  • University of Minnesota, Minneapolis
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Nagre-recruitPhase 3
  • International Diabetes Center At Park Nicollet, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
  • ACCOMPLISH-2 Research Site, Minneapolis
Edad 18 hanggang 79 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07654374

tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity

Nagre-recruit
  • Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05225233

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Nagre-recruitPhase 2
  • Children's Hospitals and Clinics of Minnesota, Minneapolis
Edad 7 hanggang 25 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05082519

A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity

Nagre-recruitPhase 4
  • Clinical Research Institute of Minnesota, Minneapolis
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07728383

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Nagre-recruit
  • Minneapolis VA Health Care System, Minneapolis
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06390345

Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults

Nagre-recruitPhase 1/2
  • University of Minnesota, Minneapolis
Edad 21 hanggang 75 · Lahat ng kasarian · Na-update Dis 17, 2025 · NCT06226077

Pag-aaral para sa Obesity sa ibang lungsod

Iba pang pag-aaral sa Minneapolis

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.